Badania in vitro nad niedokrwistościa towarzyszaca przewlekłym stanom zapalnym. Wpływ remombinowanej interleukiny-1 beta na ludzka erytropoezee.

Translated title of the contribution: In-vitro study of anemia in chronic inflammatory conditions. Effect of recombined interleukin-1 beta on human erythropoiesis

M. Z. Ratajczak, J. Ratajczak, W. I. Kuczyński, T. Skórski

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Study was inspired by the suggestion that interleukin 1-beta (IL-1 beta), one of the major inflammatory mediators, is directly responsible for anaemia of chronic inflammatory conditions. Effect of IL-beta was studied in vitro on methyl cellulose cultures of normal human bone marrow cells, the inoculate having been previously highly enriched in progenitor and stem cells. Our data did not support results reported by others that IL-1 beta is a strong inhibitor of early stages of erythropoiesis in vitro measured by early and late BFU-E formation. About 30% statistically not significant CFU-E inhibition was observed. Above studies show that IL-1 beta role in the development of anaemia associated with chronic inflammatory diseases requires further studies.

Translated title of the contributionIn-vitro study of anemia in chronic inflammatory conditions. Effect of recombined interleukin-1 beta on human erythropoiesis
Original languagePolish
Pages (from-to)97-104
Number of pages8
JournalPolish Archives of Internal Medicine
Volume91
Issue number2
StatePublished - Feb 1994

Keywords

  • Anemia/etiology
  • Bone Marrow
  • Cells, Cultured
  • Chronic Disease
  • Erythropoiesis/physiology
  • Humans
  • Inflammation/complications
  • Interleukin-1/physiology
  • Recombinant Proteins

Fingerprint

Dive into the research topics of 'In-vitro study of anemia in chronic inflammatory conditions. Effect of recombined interleukin-1 beta on human erythropoiesis'. Together they form a unique fingerprint.

Cite this